Ultrapure Dialysate for Hemodialysis and Related Therapies, AAMI TIR43:2011
ANSI/AAMI/ISO 23500:2011 makes a recommendation that ultrapure dialysate should be used for routine hemodialysis. This is not currently the standard of practice in the U.S. The objective of TIR43:2011 is to provide dialysis clinics with background information to understand the rationale for the inclusion in ISO 23500 of this recommendation and useful strategies for implementing practices to allow provision of ultrapure dialysate. The premise for the recommendation is that improving the microbiological quality of dialysate results in reduced chronic micro-inflammation and thus a reduction in the long-term of effects of inflammation and associated morbidities in dialysis patients.
This webinar explores clinical and other data supporting the premise and point out where the data is controversial. While the best interest and well-being of dialysis patients is important to all dialysis practitioners, implementing ultrapure dialysate therapy requires significant changes in practice. Facility personnel should have sufficient information to understand what the change would mean and be able to make informed and appropriate decisions regarding implementing this change in therapy delivery.
| WHO SHOULD PURCHASE |
|
| This program is designed for those who are responsible for delivering quality dialysis to ESRD patients, those who maintain the equipment and systems necessary to deliver hemodialysis therapy, and those who are responsible for CMS regulatory compliance. Personnel who design, develop, manufacture, and utilize concentrates, water treatment systems, and systems for delivery of ultrapure dialysate will also benefit from this program. |
|
| QUESTIONS? | |
For questions about ordering the CD, please contact AAMI publications at 1-877-249-8226 or 240-646-7031. |
|
PROGRAM OBJECTIVES
- Define ultrapure dialysate, rationale for use and how to prepare it
- Discuss data to support use of ultrapure dialysate
- List patient benefits reported with the use of ultrapure dialysate
- Describe changes in disinfection and monitoring needed when using ultrapure dialysate
SPEAKER
- Jo-Ann B. Maltais, Independent Consultant, Maltais Consulting, San Ramon, CA
Member AAMI Renal Disease and Detoxification Committee and Sterilization Standards Committee
WEBINAR CD
- Includes pdf of handout materials and webinar recording on CD.
- $50 for webinar registrants
- $75 for non-registrants
- domestic and international shipping rates apply
WAYS TO PURCHASE
- Online - Buy online.
- Phone - 1-877-249-8226 or 240-646-7031 to order with a credit card.
- Fax - Select and download the order form and fax to 240-396-5781.
- Mail - Select and download the order form and mail with payment to:
AAMI Webinar CD
Ultrapure Dialysate for Hemodialysis and Related Therapies, AAMI TIR43:2011
PO Box 0211
Annapolis Junction, MD 20701-0211